Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Diabetes Mellitus, Type 2 1 Diabetes Mellitus 1

Interventions

pembrolizumab 439 Carboplatin 323 Nivolumab 291 Cyclophosphamide 281 Specimen Handling 271 Magnetic Resonance Spectroscopy 257 Cisplatin 254 Paclitaxel 249 Radiotherapy 229 Gemcitabine 183 Biopsy 182 Dexamethasone 181 durvalumab 169 atezolizumab 151 Rituximab 138 Doxorubicin 135 Lenalidomide 134 Bevacizumab 133 Docetaxel 131 Ipilimumab 129 Capecitabine 120 Radiation 118 Radiosurgery 114 Oxaliplatin 114 Pemetrexed 113 Etoposide 111 Fluorouracil 110 venetoclax 108 fludarabine 106 Prednisone 97

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × saxagliptin × Clear all

NCT07033585 2025-07-11

GD-T2D

Medicine Invention Design, Inc

Phase 2/3 Active not recruiting

Diabetes Mellitus, Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡